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Abstract
Background: Hospital costs for stroke are increasing and variability in care quality creates inefficiencies. In 2007, the
Victorian Government (Australia) employed clinical facilitators for three years in eight public hospitals to improve
stroke care. Literature on the cost implications of such roles is rare. We report changes in the costs of acute stroke
care following implementation of this program.
Methods: Observational controlled before-and-after cohort design. Standardised hospital costing data were
compared pre-program (financial year 2006–07) and post-program (2010–11) for all admitted episodes of stroke or
transient ischaemic attack (TIA) using ICD-10 discharge codes. Costs in Australian dollars (AUD) were adjusted to a
common year 2010. Generalised linear regression models were used for adjusted comparisons.
Results: A 20% increase in stroke and TIA episodes was observed: 2624 pre-program (age > 75 years: 53%) and 3142 post-
program (age > 75 years: 51%); largely explained by more TIA admissions (up from 785 to 1072). Average length of stay
reduced by 22% (pre-program 7.3 days to post-program 5.7 days, p< 0.001). Six hospitals provided cost data. Average per-
episode costs decreased by 10% (pre-program AUD7888 to post-program AUD7115). After adjusting for age, sex, stroke
type, and hospital, average per-episode costs decreased by 6.1% from pre to post program (p= 0.025). When length of stay
was additionally adjusted for, these costs increased by 10.8%, indicating a greater mean cost per day (p< 0.001).
Conclusion: Cost containment of acute inpatient episodes was observed after the implementation of stroke clinical
facilitators, likely associated with the shorter lengths of stay.
Keywords: Stroke, Cost-benefit analysis, Healthcare, Policy
Background
Stroke is a high cost condition, and the majority of
stroke-related costs arise from hospitalisation. In the
first year, approximately 30% of costs for stroke are
attributable to acute hospital care and 30% to inpatient
rehabilitation [1, 2]. With the expected increases in the
incidence of stroke associated with population ageing,
finding more effective and cost-effective methods of pro-
viding hospital care for acute stroke within an environ-
ment of limited resources is important.
Currently, the most successful and universally applic-
able intervention for acute stroke in reducing death and
disability is organised management in stroke units [3].
Stroke units support greater adherence to evidence-
based interventions via a dedicated and specialised inter-
disciplinary clinical team making them more efficient
than general wards [4, 5]. However, in Australia just over
half of all patients with stroke receive care in a stroke
unit and access to other evidence-based treatments
remains variable [6].
Providing a dedicated position for co-ordination or
facilitation of uptake of evidence-based care in hospital
settings, including the establishment of stroke units,
may be one solution to improve stroke care outcomes
[7, 8]. Clinical leadership and facilitation, (i.e. where an
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individual with the appropriate knowledge and skills sup-
ports clinicians to change their practice), are cornerstones
for enhancing the uptake of evidence [9]. The role of clin-
ical facilitators may include establishing improved systems
of communication, providing education and training to
upskill staff, reviewing gaps in the provision of evidence-
based practice and working with clinicians to improve the
quality of care using evidence-based strategies, such as
implementing clinical protocols [10, 11]. However, evidence
for the effectiveness of clinical facilitators in the field of
stroke remains limited [12]. In our previous work we deter-
mined that the fixed-term employment of facilitators was
effective in positively influencing stroke care in hospitals
(e.g. more patients receiving brain imaging within 24 h,
greater access to care in a stroke unit and intravenous
thrombolysis if an ischaemic stroke) [13]. It remains
unknown if there are broader benefits to hospitals associ-
ated with facilitator programs. Our aim was to describe the
costs of acute care before and after the implementation of
the stroke clinical facilitator program in Victoria, Australia.
Methods
Setting and context
In Australia, the funding of acute public hospital care is
the responsibility of the state government. The Victorian
Stroke Clinical Network (VSCN) was established by the
Victorian government in 2007. The VSCN comprised an
interdisciplinary executive committee of clinicians and
government representatives, who meet monthly, to pro-
vide board direction for policy and strategies to improve
stroke care including advancing recommendations
within the Stroke Care Strategy for Victoria. Priorities
included improving access to stroke units, thrombolysis,
and use of evidence-based care protocols [14]. The
VSCN executive endorsed the employment of clinical
facilitators for a time-limited period (i.e. 2 to 3 years) in
selected priority hospitals based on the results of a
national audit, number of patients admitted per year or
if in a regional location. The national audit program of
acute services is undertaken every two years and is used
to monitor adherence to Australian stroke clinical guide-
lines. At each participating hospital the medical records
of up to 40 consecutive patients admitted with a primary
diagnosis of stroke are retrospectively audited for patient
demographic information, adherence to recommended
processes of care and hospital-based patient outcomes
[15]. These data were used to identify priority hospitals
requiring support to improve adherence to clinical pro-
cesses of care [13].
From May 2008, these ‘Stroke Network Facilitators’
(herein referred to as Facilitators) commenced in their
roles to support the establishment of better systems of
care for stroke in the priority hospitals, including estab-
lishing stroke units and clinical protocols [12]. These
Facilitators had clinical backgrounds in nursing or allied
health disciplines and all were employed half time (e.g.
2.5 days per week), with the exception being one large
regional hospital where two Facilitators provided full-
time cover [12]. The hospitals included three metropol-
itan sites within Melbourne (Hospital [H] identification:
H4, H6, H8) and five regional sites in other locations
within Victoria (Fig. 1). Only three of these hospitals
(H1, H2, H5) had a formalised acute stroke unit prior to
the Facilitators commencing in their role [12]. The an-
nual cost of employing Facilitators ranged from $45,000
to $60,000 between 2008 and 2011 per Facilitator if
working 2.5 days per week (overall ~ $530,000 per year).
The cost of employing facilitators was borne by the Vic-
torian Department of Health and not the hospitals.
Therefore, these costs were not taken into account as
part of the analysis, which was based on anonymised
patient-level clinical costing data from hospitals.
Study design
This was an observational controlled before-and-after
cohort design study from the perspective of hospitals.
Standardised hospital episode and clinical costing data,
which were anonymised and approved for use for a
secondary purpose, were supplied by the Victorian Gov-
ernment, and were compared pre-program (financial
year [FY] 2006–07) and post-program (FY 2010–11). Eli-
gibility for inclusion in these analyses was based on hos-
pital discharge International Classification of Diseases
(ICD) 10 codes for stroke and transient ischaemic attack
(TIA). Ischaemic stroke was defined as I63, intracerebral
haemorrhage (ICH) as I61, TIA as G45 (excluding G45.4
Transient global amnesia), and Stroke, not specified (for
any particular type) as I64. All data received were based
on episodes of care and de-identified at an individual
patient-level. Therefore, a single person may have had
multiple episodes of care for stroke in the dataset. Based
on data from the Australian Stroke Clinical Registry this
is approximately 4% [16]. Further, we were unable to link
episodes and produce estimates for individual patients
because a unique personal identifier does not exist in
Australia. Only Victorian Admitted Episodes Data linked
to clinical costing data were used.
Most, but not all hospitals provide clinical costing data
as part of the annual Victorian cost-weights study [17].
All salaries and wages are allocated to different categor-
ies including nursing, medical, allied health, emergency
care, theatre, pharmacy, pathology, imaging, intensive
care or coronary care and other. Medical supplies, phar-
maceuticals, pathology equipment, imaging and hotel
expenses are also allocated [18]. Indirect costs, including
administration, research and training are also attributed
to the most appropriate cost category (please see
Additional file 1). Six of the eight participating hospitals
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provided costing data for the present study through the
Victorian Government. This was because there were de-
lays in submission of clinical costing data to the Victorian
Government, from hospitals H7 and H8, and therefore
data from one metropolitan and one regional hospital
were unavailable within the time frame of this project.
The costs of employing Facilitators were not included.
Data analysis
The data were analysed using SPSS Statistics Software
version 22 (IBM Corp., Armonk, NY). Descriptive sta-
tistics, using parametric and non-parametric methods
appropriate for the data, were used, as well as gener-
alised linear regression modelling of costs with
gamma distributions and log linked for multivariable
analyses that adjusted for age, sex, stroke type, and
length of stay. Costs were adjusted (i.e. inflated) to a
common reference year using the total health price
index of 1.0813 for inflating 2006–07 prices to 2010–
11 prices [19]. To convert costs to United States dol-
lars please multiply by 1.5 which was the purchasing
power parity in 2011 [20].
Results
The number of episodes of care in 2010–11 increased in
all hospitals, on average by 20% since 2006–07 (Table 1).
The median number of episodes contributed by the hos-
pitals in 2006–07 was 248 (interquartile range [IQR]:
157–522) and for 2010–11 was 283 (IQR: 208–594). The
three hospitals located in the Melbourne metropolitan
local government area had a greater number of episodes
in both periods with the exception being H2 which is
located in the most populous regional area outside of
Melbourne (Table 1). Age distributions for the compari-
son periods are presented in Fig. 2. Overall, there was a
43% increase in the number of patients with stroke or
TIA admitted who were aged under 55 years, 21% in-
crease if aged 55–64 years, 17% increase among those
aged 65 to 74 years, 9% increase if aged 74–84 years, and
27% increase among those aged 85+ years. Age and sex
distributions were also similar between periods for the
different stroke types (Additional file 1: Table S1).
Table 2 provides information on the number of epi-
sodes, length of stay, total costs and the average cost
per episode in each comparison period by stroke type
and overall. In 2010–11 there were greater numbers of
TIA episodes and fewer strokes classified as type ‘not
specified’. Despite the increasing numbers of episodes,
the length of stay was significantly reduced over time,
by an average of 22% (Table 2). A one day reduction in
median length of stay between 2006 and 07 (median 4;
IQR 1–9 days) and 2010–11 (median 3; IQR 1–7 days)
(p < 0.001) was observed. This is mainly explained by
shorter lengths of stay for ischaemic stroke (2006–07
median 7; IQR 4–13 days vs. 2010–11 median 5; IQR
3–9 days; p < 0.001) and no change over time was
Fig. 1 Location of participating hospitals. The map depicted in Fig. 1 was created by the authors by adapting images freely available online. The
map of Australia was sourced from: https://pixabay.com/en/australia-continent-geography-map-23497/ and the map of Victoria was sourced from:
https://pixabay.com/en/victoria-map-australia-state-23535/ Hospital bed numbers as accessed 10th January 2017 https://www2.health.vic.gov.au/
hospitals-and-health-services/public-hospitals-victoria ^ Recent relocation of some services to another campus within health service; * includes on
site in-patient rehabilitation beds
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noted in median values for length of stay among
patients admitted with ICH (2006–07 median 3; IQR
1–9 days vs. 2010–11 median 3; IQR 1–7 days; p = 0.136).
The analysed episodes reflected a total of 19,037 patient
bed-days (total episodes/total number of days) in these
acute hospitals in 2006–2007 with a 7% decrease to
17,763 bed-days in 2010–2011. The proportion of beds
occupied at any given time by patients with ICH remained
stable at 11.2 to 11.4% while the proportion of ischaemic
stroke was reduced from 61.9 to 60.8%, and the propor-
tion of patients with TIA increased from 11.6 to 15.5%.
Additional results at an individual hospital level and
aggregated by stroke type, where relevant, are provided
in (Additional file 1: Tables S1-S4).
Differences in hospital costs
Overall, the six hospitals with clinical costing data spent
AUD13.5 million in the care of these patients in 2006–7
and AUD15.6 million in 2010–11, a 16% increase (Table 2).
However, the average per-episode costs decreased by 10%
over the 4 years (2006–7 AUD7888 versus 2010–11
AUD7115) (Table 2). After adjusting for patient age, sex,
stroke type, and hospital, there was a 6.1% decrease in aver-
age per-episode costs between 2006 and 2010 (95% confi-
dence interval 0.9 to 11.4%; p = 0.022). However, if length
of stay was additionally adjusted for, a 10.8% increase in
total cost was observed (95% confidence interval 7.2 to
14.3%, p < 0.001), illustrating the increase in cost per day. In
other words, the average cost per episode decreased by
6.1%, but the average cost per day increased by 10.8%.
Hospitals with the largest reductions in length of stay
(Additional file 1: Table S2) had evidence of the most
marked cost containment as shown in Additional file 1:
Table S3 (Total in-hospital costs by hospital) and Additional
file 1: Table S4 (Average per-episode total inpatient costs by
hospital)). After adjusting for length of stay and patient
Fig. 2 Patient age distributions by study period
Table 1 Total episodes of care by acute hospital, stroke type and year
Hospital ID Ischaemic stroke Intracerebral haemorrhage Stroke, not specified TIA Total
Financial Year 2006–07 2010–11 2006–07 2010–11 2006–07 2010–11 2006–07 2010–11 2006–07 2010–11 Δ%
Hospitals in regional Victorian locations
H1 65 101 21 25 29 27 47 60 162 213 31%
H2 242 269 59 66 42 50 154 184 497 569 14%
H3 44 73 17 21 52 45 29 52 142 191 35%
H7 70 79 15 20 54 51 56 103 195 253 30%
H5 44 45 15 17 26 29 37 55 122 146 20%
Hospitals in Melbourne metropolitan location
H6 242 407 49 79 134 77 171 226 596 789 32%
H4 153 142 25 31 30 35 92 104 300 312 4%
H8 250 249 72 53 89 79 199 288 610 669 10%
Total 1110 1365 273 312 456 393 785 1072 2624 3142 20%
Total Δ% 23% 14% −14% 37% 20%
H hospital, TIA transient ischaemic attack, Δ% percentage change from 2006 to 07 to 2010–2011, ID hospital identification number
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characteristics, there were still differences among the hospi-
tals in 2010–11 between the most expensive (H1: regional
site) and least expensive (H3 regional site p= 0.005, H5 re-
gional site p < 0.001) hospitals in our sample (Fig. 3). Break-
down of mean unadjusted cost per episode in 2010–11 is
displayed in Additional file 1: Figure S1. In 2010–11, the
main unadjusted cost components overall were nursing
(44%), medical (14%), allied health (13%), emergency depart-
ment (9%), and imaging (8%) (Additional file 1: Figure S2).
Differences in mean episode costs for each category were
compared between 2006-07 and 2010–11. Allied health,
emergency, and imaging costs increased (p < 0.01) while
nursing, medical and pathology costs decreased (all p <
0.001) over the study period. For all other categories, no sig-
nificant differences were observed.
Discussion
Clinical facilitators are recognised as important for im-
proving evidence-based practice as part of organisational
redesign or achieving task oriented objectives [10, 11, 13,
21]. To our knowledge, we report for the first time on
changes in acute hospital costs associated with investment
in Facilitators employed to support improvements in the
quality of acute stroke care at priority hospitals. Employed
for 3-years, the Facilitators in our study had no clinical
caseload as part of their role and were able to establish
standardised clinical protocols and care plans, and new
dedicated stroke units where these were required [13].
The observed changes in practice included increased
access to Stroke Units (pre-facilitator 53%; post 86%
p < 0.001); intravenous thrombolysis (pre-facilitator
2%; post 9% p < 0.001) and TIA protocols became
available in all sites where previously only 50% pro-
vided these [22]. Program success factors included
sharing of information between the participating hos-
pitals to reduce duplication of effort and the clinical
teams having increased capacity to undertake clinical
quality improvement projects.
Table 2 Summary results by stroke type and year
Ischaemic stroke Intracerebral haemorrhage Stroke, not specified TIA Total
2006–07 2010–11 2006–07 2010–11 2006–07 2010–11 2006–07 2010–11 2006–07 2010–11
Episodes of care 1110 1365 273 312 456 393 785 1072 2624 3142
Δ% 23% 14% −14% 37% 20%
Average LOS 10.6 7.9 7.8 6.5 6.4 5.5 2.8 2.6 7.3 5.7
Δ% −25%† −17% −13% −9% −22%†
Costing dataa
Total costs (‘000 s) $8109 $9653 $1586 $1960 $2188 1678 $1605 $2198 $13,488 $15,589
Δ% 19% 24% −23% 43% 16%
Average per episode cost $11,093 $9418 $9275 $8447 7245 6454 $3171 $3409 $7888 $7115
Δ% −19%† −20% −5% 4% −10%†
TIA transient ischaemic attack, Δ% percentage change from 2006 to 07 to 2010–2011. All costs are in 2010 Australian dollars. aTwo hospitals are not included
since their clinical costing data were not supplied. † t-test p < 0.01, all others p > 0.1
Fig. 3 Average costs (in Australian dollars) per episode for 2010–11 adjusted for patient characteristics and length-of- stay. Estimated marginal means
and 95% confidence intervals of a generalised linear model with gamma distribution and log link adjusting for age, sex, stroke type, and length of stay.
H = hospital. hHospital H4 and H6 were located in the Melbourne metropolitan area (other hospitals are in a regional location within Victoria)
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Overall, indications of greater efficiency and capacity to
manage more patients with stroke or TIA as inpatients
within the context of fewer bed-days being occupied were
found. Despite an observed 20% increase in patient epi-
sodes, the number of bed-days utilised was fewer, but the
average cost per bed-day was larger (2006–07 AUD709
per day; 2010–11 AUD878 per day). Reassuringly we
found evidence of cost containment, with the average total
inpatient costs per-episode decreasing by 10% over 4
years. The cost containment is explained by reductions in
average length of stay, a changing case-mix of patients
and the need for hospitals to improve their admission and
discharge processes to accommodate greater number of
patients. These efforts would have been augmented by the
achievements of the Facilitators in creating more stream-
lined management processes including access to rehabili-
tation services [13].
Our observed reduction in length of stay averaged
4.1% over the 5 year study period in our priority hospi-
tals with Facilitators, and provides evidence that not all
of this reduction is explained by system-wide downward
trends. An average annual decrease of 2.1% in length of
stay between 2007 and 08 and 2011–12 among acute
care public hospitals in Australia, and with same-day
separations excluded, has been reported [23]. Several
explanations for our findings are possible, including that
there were proportionally more TIA episodes than stroke
episodes, and that patients with TIA had shorter lengths
of stay than patients with stroke.
The absolute average cost of an episode decreased
(− 6%). When length of stay was additionally adjusted
for, the cost per day increased by ~ 11% highlighting
that reductions in lengths of stay do not necessarily
result in overall savings. This is because approxi-
mately 40% of the variable costs are incurred during
the first three days of admission [24]. Reductions in
length of stay influence the less expensive days in
hospital, and with greater efficiency more patients can
be treated, but each bed day is more costly [24]. This
was explained by a shift in resource utilisation
whereby allied health, emergency, and imaging costs
were greater contributors to the overall costs in
2010–11 while nursing, medical and pathology costs,
usually associated with ongoing care in hospital de-
creased for this period when compared with 2006–07
(Additional file 1).
The differences in stroke type patterns may be a con-
sequence of improved documentation and coding, as
well as better diagnostic work up [13]. This shift in
case-mix may also reflect differences in transfer policies
within the geographical areas serviced by these hospitals
that have now established stroke units.
There have been very few published studies de-
signed to explore the influence of clinical facilitator
roles and hospital costs [25, 26], and none to our
knowledge in stroke. In the study by Sakallaris et al.
(2000), use of a facilitator early in the process to es-
tablish same-day transfer protocols to a cardiac tel-
emetry unit after surgery resulted in cost savings and
was achieved without compromising the quality of
care (assessed by measuring rates of readmission to
the ICU or hospital) [26]. Other related studies include
use of clinical pathways. In the most recent systematic re-
view by Rotter and colleagues it was concluded that use of
clinical pathways was the most likely explanation for the
observed reduced lengths of stay and costs [27]. This is
consistent with our findings, which also highlight import-
ant efficiency gains despite the increased numbers of ad-
missions. Future research is needed to verify our findings
or provide cost-effectiveness evidence against other poten-
tial models of facilitation in stroke care. This includes a
comparison against stroke coordinator roles that are fully
embedded within hospitals [7]. In this way, the value of
these alternate options for improving stroke care could
more effectively guide policy decision-making.
Strengths of the study include use of comprehensive
episode-based costing data for whole financial years ob-
tained using reliably applied clinical costing standards
[18] and categorised by resource type and stroke type
to provide fuller explanatory information. It has been
found that the precision of estimates from the Victorian
clinical costing data and generalizability to overall Vic-
torian inpatient care is very good, and that by obtaining
costs at an ICD10 rather than diagnostic-related group
level, we were more likely to have consistency in classi-
fication of patients and costs [28].
Potential limitations include that the evaluation of
costs presented here relies on the reliability of ICD-10
discharge codes. However, the method for assigning the
nominated ICD-10 discharge codes is unlikely to have
changed between these periods. There was also evidence
of improved diagnostic classification whereby fewer un-
specified strokes were reported in the 2010–11 cohort,
but this would not have influenced our overall cost re-
sults. In addition, we were unable to follow individual
patients and the cost per patient could not be derived
since the data were de-identified. It is likely that a small
number of individuals (~ 4%) [16] will appear several
times in the dataset. Re-hospitalisations may artificially
increase the number of episodes and decrease the aver-
age costs per episode.
It cannot be assumed that all the benefits observed
are fully attributable to the Facilitator program in
these hospitals. Nevertheless, the magnitude of the
changes observed are unlikely to be fully explained by
secular improvements in evidence-based practice. For
example, the evidence for the establishment of stroke
units has existed since 1993 [29], but poor access to
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stroke units is still an issue in Australia [30]. In our
primary results paper related to this program we
reported changes in processes of care in the
post-facilitator period that were much greater than
the contemporaneous equivalent data from all other
hospitals in Australia [13]. In the current study, we
also noted differences in the average costs per episode
treated between hospitals. This may in part be
explained by teaching and research activities allocated
as indirect costs [18]. Therefore, the metropolitan hos-
pitals (two of the six that provided cost data) may have
greater costs than the regional hospitals. Alternatively,
regional hospitals may be required to pay greater staff
costs due to more use of Visiting Medical Officers and
patient transport services for diagnostic tests. The small
number of sites in this analysis means that comparisons
between the metropolitan and regional sites are only indi-
cative of possible differences in resource use and should
be interpreted with caution.
Our results might also be influenced by some cost shift-
ing from the ambulatory and/or primary care sector to the
inpatient hospital sector, or from acute hospitals to
sub-acute care settings such as rehabilitation. More rapid
discharge to rehabilitation or to home settings with com-
munity supports may provide cost savings for acute hospi-
tals, but may increase costs within these other services.
Moreover, there are now a range of rapid assessment out-
patient options for managing TIA which may be more effi-
cient than care in hospitals [31]. In an ideal situation, a full
cost evaluation should include follow-up of individual
patients through the whole stroke system of care [2].
Conclusions
These data provide important new information about
changes in patterns of resource use in a sample of Victor-
ian hospitals where there has been a strong focus on im-
proving acute stroke care made possible through
Facilitators. The findings are relevant for stroke care inter-
nationally, and may also be applicable to other conditions
where variation in practice exists. Importantly, the results
highlight that health service improvements can be
achieved against a background of increased activity and
rising costs. Given the paucity of data in this area further
research is needed to verify these findings and to under-
stand the longer term sustainability impacts of implement-
ing this type of program.
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Additional file 1: Appendix 1. Description of data: In this additional
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(Australia) and additional Results are presented on information at an
individual hospital level or aggregated by stroke type in the
supplemental Tables and Figures. (DOC 331 kb)
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